Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Henk-Jan Prins, Tjip S. van der Werf, Wim G. Boersma. Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?. Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019

Member's Comments

No comment yet.

Related content which might interest you: Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Should we change our antibiotic strategy in AECOPD or CAP+COPD patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018 Year: 2019 A digital therapy for proactively managing exacerbations and delivering therapeutic benefit to patients with moderate to severe asthma Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Long-term benefits of antibiotic treatment in reducing recurrence rates and resource utilization in acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD Source: ERJ Open Res, 4 (3) 00087-2018; 10.1183/23120541.00087-2018 Year: 2018 Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD Source: International Congress 2017 – Treatment and prevention of COPD exacerbation Year: 2017 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Long-term azithromycin therapy in severe COPD with repeated exacerbations Source: Annual Congress 2010 - COPD exacerbation Year: 2010 Does long-term macrolide treatment reduce asthma exacerbations? An individual patient data meta-analysis Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021 Year: 2021 May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001